ChemicalBook > CAS DataBase List > Ramucirumab
Ramucirumab
- Product Name
- Ramucirumab
- CAS No.
- 947687-13-0
- Chemical Name
- Ramucirumab
- Synonyms
- Cyramza;LY3009806;IMC-1121B;Ramucirumab;Ramucirumab (anti-VEGFR2);Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
- CBNumber
- CB72738188
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Ramucirumab Property
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Safety
- Hazardous Substances Data
- 947687-13-0(Hazardous Substances Data)
More
Less
N-Bromosuccinimide Price
ChemScene
- Product number
- CS-0031056
- Product name
- Ramucirumab
- Packaging
- 1mg
- Price
- $400
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- FR159043
- Product name
- Ramucirumab
- Packaging
- 1mg
- Price
- $425
- Updated
- 2021/12/16
American Custom Chemicals Corporation
- Product number
- ATB0023429
- Product name
- RAMUCIRUMAB
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $498.75
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- FR159043
- Product name
- Ramucirumab
- Packaging
- 2mg
- Price
- $650
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- FR159043
- Product name
- Ramucirumab
- Packaging
- 5mg
- Price
- $1000
- Updated
- 2021/12/16
More
Less
Ramucirumab Chemical Properties,Usage,Production
Clinical Use
Human monoclonal antibody:
Treatment of advanced gastric cancer or gastrooesophageal junction adenocarcinoma, colorectal
cancer and non-small cell lung cancer (NSLC)
target
VEGFR2
Drug interactions
Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live
vaccines - avoid.
Metabolism
The metabolism of ramucirumab has not been studied. Monoclonal antibodies are mainly cleared by catabolism.
Ramucirumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Ramucirumab Suppliers
- Tel
- --
- Fax
- --
- Country
- India
- ProdList
- 4
- Advantage
- 58
947687-13-0, RamucirumabRelated Search:
Adalimumab
Ustekinumab
Nivolumab
Bevacizumab
Daratumumab
OMALIZUMAB
Lambrolizumab
Dulaglutide
Infliximab
Rituximab
palivizumab
Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
Atezolizumab
Denosumab
CETUXIMAB
Evolocumab
ipilimumab
Eculizumab